Heart Failure Management Guideline

A randomized clinical trial that also was published in JAMA. So it was on the effect of the PCSK9 inhibitor, Alarochumab, when added to high intensity statin therapy. This is an incredibly important study and it was really looking at what is the optimal management strategy for dyslipidemia or of LDL cholesterol after acute myocardial infarction.